Small Molecule Drug Clinical Trial Pre-screening: Citation

Data Characteristics for This Category

Small molecule drug clinical trial pre-screening data originates from compound structure databases, in vitro/in vivo efficacy experimental data, toxicology reports, preclinical research reports, and published scientific literature. This data typically exists as structured database entries, unstructured text reports, and semi-structured tables. Compound structure data (e.g., SMILES strings, InChIKey) updates relatively stably. Clinical trial progress and efficacy data may update frequently as experimental phases advance. Document structures vary, including PDF experimental reports, Word document protocol designs, and Excel table experimental results. Fields cover compound ID, target, mechanism of action, IC50/EC50 values, PK/PD parameters, and adverse event data. Common units include nM, µM, mg/kg, and h, requiring precise parsing.

Constraints from These Characteristics on Citation and Traceability

The diversity of small molecule drug data sources requires unified management of citations. Citations of precise numerical values, such as compound structures and efficacy parameters, require the system to accurately identify and link to original data points, ensuring traceability accuracy. Extensive unstructured text in preclinical reports, such as toxicology descriptions and pharmacokinetic analyses, requires efficient text parsing to extract key information and establish citation links. Due to varying data update frequencies, the citation traceability mechanism must handle version control, ensuring citations point to a specific data version at a given time. Differences in fields and units across data sources, for example, IC50 values potentially having different units, require the citation system to standardize or provide clear unit annotations to avoid information confusion.

Configuration Recommendations

Configuration Item	Suggested Value	Rationale
`maxContext`	`2000 characters`	Ensures completeness of key paragraphs in clinical trial reports while controlling context length to improve retrieval efficiency.
`Chunk size` (Segment Length)	`500 characters`	Balances segmentation of structured data entries and unstructured text, preventing semantic interruption.
`Recall count` (Recall Count)	`10 entries`	Covers multiple potentially relevant data sources and report segments, increasing the breadth of initial recall.
`Similarity threshold` (Similarity Threshold)	`0.78`	Balances recall precision and recall rate, reducing interference from irrelevant results, especially for numerical and technical term matching.
`Rerank result count` (Reranked Return Count)	`3 entries`	Refines the final presented citations, prioritizing the most relevant and information-dense clinical trial data or report summaries.
`PARSE_FILE_TIMEOUT_SECONDS`	`600 seconds`	Accommodates parsing time for large clinical trial reports (e.g., PDF documents), preventing file processing failures due to timeouts.

Three Common Mistakes

Citations display "source not found" even when relevant data exists in the knowledge base. This occurs due to an improper knowledge base segmentation strategy, leading to key information being truncated or semantic boundaries becoming ambiguous.
Workflow API calls return empty citation data, but global variables are configured in the knowledge base. This happens when the knowledge_base_id parameter is not correctly passed during the API call or is not associated with the knowledge base in the workflow.
Answers do not align with the knowledge base's professional content, even when citations from the knowledge base are displayed. This is because the Similarity threshold (Similarity Threshold) is set too low or the Rerank result count (Reranked Return Count) is too small, causing the model to extract information from non-core citations or failing to fully utilize important citations.

How to Confirm Proper Configuration

For typical small molecule drug queries, check if the source field in the returned answer's citations includes specific document names, page numbers, or data source identifiers.
Randomly select a citation source and verify if its content exactly matches the corresponding information in the original preclinical report or compound database, including values and units.
Simulate updating a compound's efficacy data. Observe if the system can cite the latest version of the data during a query and trace back to previous versions.

The values provided are common starting points and should be measured against the reader's own samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.